# CNOT6

## Overview
CNOT6 is a gene that encodes the protein CCR4-NOT transcription complex subunit 6, which is a critical component of the CCR4-NOT complex, a multifunctional protein assembly involved in the regulation of mRNA metabolism. The CNOT6 protein is categorized as a deadenylase, an enzyme that catalyzes the removal of poly(A) tails from mRNA molecules, thereby influencing mRNA stability and degradation. This process is essential for the regulation of gene expression and various cellular processes, including cell growth and apoptosis. The protein is characterized by its leucine-rich repeat (LRR) and endonuclease-exonuclease-phosphatase (EEP) domains, which facilitate its interactions within the CCR4-NOT complex and its enzymatic activity (Winkler2013Heterogeneity; Shirai2014Multifunctional). CNOT6 is expressed in several tissues and has been implicated in cancer biology, although its precise role in disease mechanisms requires further investigation (Chalabi2020The; Shirai2014Multifunctional).

## Structure
The human gene CNOT6 encodes a protein that is a component of the CCR4-NOT complex, which plays a crucial role in mRNA deadenylation. The CNOT6 protein is characterized by two main domains: an amino-terminal leucine-rich repeat (LRR) domain and a carboxy-terminal endonuclease-exonuclease-phosphatase (EEP) domain. The LRR domain consists of alternating α-helices and β-sheets, forming a solenoid structure that interacts with the Caf1 subunit (Winkler2013Heterogeneity). The EEP domain is associated with ribonuclease activity and has a strong preference for poly(A) residues. The crystal structure of the nuclease domain reveals an α/β-sandwich fold, similar to other hydrolases like apurinic/apyrimidinic endonuclease (APE) 1, and requires two Mg(II) ions for hydrolysis, coordinated by conserved residues such as asparagine, glutamate, aspartate, and histidine (Winkler2013Heterogeneity).

CNOT6 and its paralog CNOT6L are mutually exclusive in the CCR4-NOT complex, suggesting a competitive binding dynamic (Xu2014Insights). The protein's structure is part of a larger assembly, interacting with other proteins like CNOT1 and CNOT7/Caf1 (Xu2014Insights). Specific details on post-translational modifications or splice variant isoforms of CNOT6 are not provided in the available context.

## Function
CNOT6, also known as CCR4a, is a subunit of the CCR4-NOT complex, which plays a crucial role in mRNA deadenylation, a process essential for mRNA metabolism and turnover. This deadenylation activity involves the shortening of the poly(A) tail of mRNA molecules, leading to their degradation and thus regulating gene expression (Lau2009Human; Shirai2014Multifunctional). CNOT6 is active in the cytoplasm, where it influences various cellular processes by modulating mRNA stability and decay (Mittal2011The).

In human cells, CNOT6 is part of distinct Ccr4-Not complexes that differ in their deadenylase subunits, suggesting a role in regulating mRNA metabolism through interactions with other subunits like CNOT7 and CNOT8 (Lau2009Human). The complex is involved in linking nuclear and cytosolic functions, as CNOT6 shuttles between the nucleus and cytoplasm, indicating its involvement in mRNA synthesis, degradation, transport, and localization (Lau2009Human).

CNOT6 is highly expressed in specific tissues such as the testis, ovary, thymus, and spleen, contributing to efficient cell growth in certain cell types like MCF-7 cells (Shirai2014Multifunctional). Its role in cancer is not well understood, although it is implicated in cell proliferation and survival, particularly in breast cancer cells (Mittal2011The).

## Clinical Significance
Alterations in the expression of the CNOT6 gene have been associated with various clinical conditions, particularly in the context of cancer. A functional susceptibility locus, rs2453176 C > T, has been linked to an increased risk of lung cancer, suggesting a potential role for CNOT6 in cancer susceptibility (Chalabi2020The). In leukemia, specifically acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), CNOT6 transcripts are slightly up-regulated, indicating a possible involvement in the disease's progression (Chalabi2020The; Shirai2014Multifunctional).

The CNOT6 gene is part of the CCR4-NOT complex, which plays a role in mRNA deadenylation and regulation of gene expression. Alterations in this complex can affect cell cycle progression and apoptosis. In mammalian cells, depletion of CNOT6 leads to resistance to cisplatin-induced apoptosis, while its overexpression increases sensitivity to DNA damage, highlighting its role in the DNA damage response (Chalabi2020The; Hagkarim2023Disruption).

Despite these associations, the precise mechanisms by which CNOT6 contributes to disease onset and progression remain unclear, necessitating further research to fully understand its clinical significance (Shirai2014Multifunctional).

## Interactions
CNOT6, a subunit of the CCR4-NOT complex, participates in several protein interactions essential for its function in mRNA deadenylation. It interacts with CNOT7 and CNOT8, which are DEDD-type deadenylases, to integrate into the CCR4-NOT complex and exert its deadenylation functions (Doidge2012Deadenylation; Shirai2014Multifunctional). These interactions are crucial for the structural stability of the complex, as CNOT7 and CNOT8 also play a structural role by interacting with the leucine-rich repeat domains of CNOT6, stabilizing its association within the complex (Doidge2012Deadenylation).

CNOT6 also interacts with the middle region of CNOT1 through the MIF4G domain, although it does not directly bind to CNOT1 (Shirai2014Multifunctional). The interaction with CNOT7 is particularly significant, as it is essential for the deadenylation process mediated by the CCR4-NOT complex (Otsuka2020AREbinding). These interactions highlight the role of CNOT6 in the regulation of mRNA stability and degradation, contributing to the complex's overall function in mRNA metabolism and cellular homeostasis (Shirai2014Multifunctional).


## References


[1. (Otsuka2020AREbinding) Hiroshi Otsuka, Akira Fukao, Takumi Tomohiro, Shungo Adachi, Toru Suzuki, Akinori Takahashi, Yoshinori Funakami, Toru Natsume, Tadashi Yamamoto, Kent E. Duncan, and Toshinobu Fujiwara. Are-binding protein zfp36l1 interacts with cnot1 to directly repress translation via a deadenylation-independent mechanism. Biochimie, 174:49–56, July 2020. URL: http://dx.doi.org/10.1016/j.biochi.2020.04.010, doi:10.1016/j.biochi.2020.04.010. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.biochi.2020.04.010)

[2. (Shirai2014Multifunctional) Yo-Taro Shirai, Toru Suzuki, Masahiro Morita, Akinori Takahashi, and Tadashi Yamamoto. Multifunctional roles of the mammalian ccr4â€“not complex in physiological phenomena. Frontiers in Genetics, August 2014. URL: http://dx.doi.org/10.3389/fgene.2014.00286, doi:10.3389/fgene.2014.00286. This article has 98 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2014.00286)

[3. (Winkler2013Heterogeneity) G. Sebastiaan Winkler and Dario L. Balacco. Heterogeneity and complexity within the nuclease module of the ccr4-not complex. Frontiers in Genetics, 2013. URL: http://dx.doi.org/10.3389/fgene.2013.00296, doi:10.3389/fgene.2013.00296. This article has 35 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2013.00296)

[4. (Mittal2011The) Saloni Mittal, Akhmed Aslam, Rachel Doidge, Rachel Medica, and G. Sebastiaan Winkler. The ccr4a (cnot6) and ccr4b (cnot6l) deadenylase subunits of the human ccr4–not complex contribute to the prevention of cell death and senescence. Molecular Biology of the Cell, 22(6):748–758, March 2011. URL: http://dx.doi.org/10.1091/mbc.e10-11-0898, doi:10.1091/mbc.e10-11-0898. This article has 88 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1091/mbc.e10-11-0898)

[5. (Doidge2012Deadenylation) Rachel Doidge, Saloni Mittal, Akhmed Aslam, and G. Sebastiaan Winkler. Deadenylation of cytoplasmic mrna by the mammalian ccr4–not complex. Biochemical Society Transactions, 40(4):896–901, July 2012. URL: http://dx.doi.org/10.1042/bst20120074, doi:10.1042/bst20120074. This article has 65 citations and is from a peer-reviewed journal.](https://doi.org/10.1042/bst20120074)

[6. (Chalabi2020The) Nafiseh Chalabi Hagkarim and Roger J. Grand. The regulatory properties of the ccr4–not complex. Cells, 9(11):2379, October 2020. URL: http://dx.doi.org/10.3390/cells9112379, doi:10.3390/cells9112379. This article has 39 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells9112379)

[7. (Lau2009Human) Nga-Chi Lau, Annemieke Kolkman, Frederik M. A. van Schaik, Klaas W. Mulder, W. W. M. Pim Pijnappel, Albert J. R. Heck, and H. Th. Marc Timmers. Human ccr4–not complexes contain variable deadenylase subunits. Biochemical Journal, 422(3):443–453, August 2009. URL: http://dx.doi.org/10.1042/bj20090500, doi:10.1042/bj20090500. This article has 167 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj20090500)

[8. (Hagkarim2023Disruption) Nafiseh Chalabi Hagkarim, Morteza Chalabi Hajkarim, Toru Suzuki, Toshinobu Fujiwara, G. Sebastiaan Winkler, Grant S. Stewart, and Roger J. Grand. Disruption of the mammalian ccr4–not complex contributes to transcription-mediated genome instability. Cells, 12(14):1868, July 2023. URL: http://dx.doi.org/10.3390/cells12141868, doi:10.3390/cells12141868. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells12141868)

[9. (Xu2014Insights) Kun Xu, Yuwei Bai, Aili Zhang, Qionglin Zhang, and Mark G. Bartlam. Insights into the structure and architecture of the ccr4â€“not complex. Frontiers in Genetics, May 2014. URL: http://dx.doi.org/10.3389/fgene.2014.00137, doi:10.3389/fgene.2014.00137. This article has 29 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2014.00137)